Development and validation of nomograms for predicting survival in patients with de novo metastatic triple-negative breast cancer

HIGHLIGHTS

  • who: Mao-Shan Chen from the DepartmentSichuan University have published the article: Development and validation of nomograms for predicting survival in patients with de novo metastatic triple-negative breast cancer, in the Journal: Scientific Reports Scientific Reports
  • what: The nomograms have been established and validated for predicting BCSS and OS in TNBC patients with metastatic disease, which hold promises in realizing individualized prognostic prediction and identifying the high-risk patients who require more specialized treatment strategies and follow-up plans.

SUMMARY

    After acquiring the access, the authors extracted eligible cases from . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?